What is the CGEM stock price prediction for next 2 weeks?

According to our price prediction algorithm,Cullinan Therapeutics, Inc. (CGEM) price will be around $19.74 in the next 2 weeks. This means it will decrease by -4.1345313258863445 from the last closing price. This prediction may vary from other time period filters for CGEM stock.

What can be the highest Possible price of CGEM stock in next 2 weeks?

Our forecast algorithm expects that in 2 weeks, CGEM can achieve the highest price of $20.52 which is -0.36037324593651765 lower than last closing price. This prediction may vary from other time period filters for CGEM stock.

What can be the lowest Possible price of CGEM stock in next 2 weeks?

As per the forecast and algorithmic analysis, CGEM stock price can be as low as $18.98 which is -7.831348535917792 lower than the current price in the next 2 weeks. This prediction may vary from other time period filters for CGEM stock.

Will CGEM stock go high in the next 2 weeks?

No, our stock forecasting algorithm shows that CGEM stock will lose-4.1345313258863445 in the next 2 weeks. This prediction may vary from other time period filters for CGEM stock.

What is CGEM stock last closing price?

Last closing price of CGEM stock was $20.59.

What is CGEM stock price prediction?

CGEM stock price prediction means predicting the future closing prices of CGEM stock based on its past data. Our forecasting algorithm uses various machine learning and deep learning techniques to forecast the future behavior of CGEM stock in a certain time period.

How we predict CGEM stock future prices?

If you are searching for CGEM stock forecast, analysis or price prediction, then you might be wondering what Cullinan Therapeutics, Inc. (CGEM) will do in the future. Our CGEM price predictions are based on various Machine Learning based algorithms with an aim to try and predict future price movements. This CGEM price prediction will likely answer most of your questions.

How frequent we update CGEM stock predictions?

We are updating the forecasts for the CGEM stock on daily basis.

Is using ML forecasting for CGEM stock a good way?

Yes. Stock Price Prediction is one of the most exciting applications of Machine Learning. By leveraging data from the past, it is possible to use forecasting models to make accurate predictions about future stock prices. This can be incredibly beneficial for investors and traders, as it gives them the ability to make more informed decisions about when to buy and sell. Investing in the stock market can be a risky endeavor, but leveraging Machine Learning can make it a bit less daunting and more profitable.

Is the Prediction for CGEM stock same for all the time periods?

No, the prediction for CGEM stock is not same for all time periods. The forecasts may vary depending on the differences in the time period.

Cullinan Therapeutics, Inc. Stock Forecast and Stock Price Prediction

Stock Forecast Chart

Stock Price Prediction Summary

Closed Price$20.59-5.12%Since 2 Weeks

Predicted Price$19.74-4.13%For 2 Weeks

Upper Predicted Price$20.52-0.36%For 2 Weeks

Lower Predicted Price$18.98-7.83%For 2 Weeks

Forecast Score Based on 2 Weeks

Based on our forecast, the price of CGEM will decline by -4.13% over the next 2 Weeks and hit $19.74 by Friday, September 25, 2026. In that time frame, CGEM's share price is expected to range between $18.98 and $20.52.

BearishAverageBullish

Date	Predicted Lower	Predicted	Predicted Upper
Sep 25, 2026	18.98	19.74	20.52
Sep 24, 2026	19.36	20.09	20.81
Sep 23, 2026	19.66	20.32	20.93
Sep 22, 2026	19.65	20.25	20.84
Sep 21, 2026	19.31	19.84	20.35
Sep 18, 2026	19.67	20.18	20.65
Sep 17, 2026	20.07	20.53	20.97
Sep 16, 2026	20.30	20.76	21.19
Sep 15, 2026	20.26	20.69	21.14
Sep 14, 2026	19.87	20.28	20.69

CGEM shares fell -1.95% in Friday, September 11, 2026's trading session, dropping from a previous close of $21.00 to move at $20.59. The stock demonstrated notable intraday movement (see CGEM's key stats for a full breakdown), fluctuating between $20.10 and $21.34, a +6.17% trading range. While recent weeks have seen some volatility, CGEM has managed to secure a -5.12% drop over the past 2 weeks. The downward price movement was accompanied by increased trading volume, with approximately 1.09M shares changing hands, 284.71K more than the previous session. This amounted to $22.45M in total market activity.

Will CGEM Continue Its Downward Trend?

According to analyst ratings and projections for CGEM, Cullinan Therapeutics, Inc. shares are anticipated to decrease by -0.36%, potentially reaching $20.52 per share by September 25, 2026. Short-term technical indicators currently suggest a neutral sentiment for CGEM. For deeper insights, view our sentiment analysis on AAPL covering social and institutional perspectives. However, the stock has recorded 15 positive trading days within the past 30 sessions. Based on the CGEM stock forecast, now is not the best time to buy CGEM stock because its current trading price is +4.31% above our predicted value, hinting at a possible undervaluation. For deeper insights, view our sentiment analysis on CGEM covering social and institutional perspectives.

CGEM Technical Momentum: Overbought, Oversold, or Neutral?

An analysis of Relative Strength Index (RSI) indicators provides insight into CGEM's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 38.98% to 52.47%) suggest mixed signals, with the stock in a neutral to slightly bearish momentum phase. The 50-day RSI, at 56.12%, suggests a neutral medium-term outlook. Additionally, the 100-day RSI, at 55.85%, maintains a neutral outlook for the long term. Insights into CGEM's shareholder base show how institutional investors are positioning themselves during these momentum shifts

Cullinan Therapeutics Short-Term Forecasts

CGEM Forecast For Next 5 Days

Our algorithm anticipates Cullinan Therapeutics (CGEM) stock could hit $21.66 by Sep 18, 2026. This represents a +5.19% rise from today's price, following a +2.45% change over the past five days.

CGEM Forecast For Next 30 Days

Based on analysis of market trends, the outlook for Cullinan Therapeutics, Inc. (CGEM) stock over the next 30 days is largely positive. Price forecasts suggest an average target of $21.30, which would mean a +3.45% increase from the current price of $20.59. Projections for this period range from a high of $25.09 to a low of $17.81.

CGEM Forecast For Next 90 Days

Our proprietary market analysis suggests predictions for Cullinan Therapeutics's price over the next three months point to a rise. CGEM stock is expected to peak at $23.69 on Nov 25, 2026 after potentially dipping to $16.72 on Oct 12, 2026. On average, CGEM is likely to trade around $21.03 in the coming 90 days.

Cullinan Therapeutics Stock Forecast 2025

Based on our predictive models, Cullinan Therapeutics (CGEM) is expected to trade between $16.72 and $23.69 throughout 2026. This would result in an average price of $21.06, potentially offering investors a +2.28% return from current levels.

Cullinan Therapeutics, Inc. Monthly Forecast 2026–2027

September 2026

According to our latest forecast models, Cullinan Therapeutics, Inc. (CGEM) is positioned to show a strong performance in September 2026. The price is predicted to move between $18.60 and $23.01, settling at an average of $20.85. This could translate to a +1.26% gain.

October 2026

Based on current market signals, Cullinan Therapeutics, Inc. is projected to trend october 2026. We forecast a trading range from $16.72 to $23.64, with a likely average price of $21.15. Investors could expect a potential return of +2.72%.

November 2026

Our predictive algorithms indicate Cullinan Therapeutics, Inc. stock may see a shift in November 2026. The expected range spans $18.42–$23.69, with an average target of $21.16. This represents a positive outlook and a possible gain of +2.77%.

December 2026

Analyzing established trends, Cullinan Therapeutics, Inc. looks set to move in December 2026. Projections place the stock between $18.36 and $23.40, averaging around $21.01. This suggests a +2.04% gain from current levels.

January 2027

Market indicators suggest Cullinan Therapeutics, Inc. could experience notable changes during January 2027. Prices could fluctuate within $19.30 to $24.28, with a midpoint forecast of $21.86. The stock might deliver a +6.17% gain.

February 2027

Forecasting for February 2027, models estimate that Cullinan Therapeutics, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $18.69 and $23.17, averaging $20.94. This signals a positive trajectory with potential returns around +1.70%.

March 2027

According to our latest forecast models, Cullinan Therapeutics, Inc. (CGEM) is positioned to show a strong performance in March 2027. The price is predicted to move between $19.10 and $23.74, settling at an average of $21.24. This could translate to a +3.16% gain.

April 2027

Based on current market signals, Cullinan Therapeutics, Inc. is projected to trend april 2027. We forecast a trading range from $18.67 to $23.74, with a likely average price of $21.15. Investors could expect a potential return of +2.72%.

May 2027

Our predictive algorithms indicate Cullinan Therapeutics, Inc. stock may see a shift in May 2027. The expected range spans $18.64–$23.30, with an average target of $21.00. This represents a positive outlook and a possible gain of +1.99%.

June 2027

Analyzing established trends, Cullinan Therapeutics, Inc. looks set to move in June 2027. Projections place the stock between $19.34 and $24.24, averaging around $21.83. This suggests a +6.02% gain from current levels.

July 2027

Market indicators suggest Cullinan Therapeutics, Inc. could experience notable changes during July 2027. Prices could fluctuate within $18.73 to $23.37, with a midpoint forecast of $20.90. The stock might deliver a +1.51% gain.

August 2027

Forecasting for August 2027, models estimate that Cullinan Therapeutics, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $18.63 and $23.89, averaging $21.27. This signals a positive trajectory with potential returns around +3.30%.

September 2027

According to our latest forecast models, Cullinan Therapeutics, Inc. (CGEM) is positioned to show a strong performance in September 2027. The price is predicted to move between $18.68 and $23.05, settling at an average of $20.78. This could translate to a +0.92% gain.

CGEM's history of dividends and stock splits also plays a role in long-term investor confidence.